Indraprastha Medical Corporation Limited (NSE:INDRAMEDCO)
India · Delayed Price · Currency is INR 507.50
+35.65 (7.56%)
Sep 10, 2025, 3:29 PM IST
NSE:INDRAMEDCO Market Cap
NSE:INDRAMEDCO has a market cap or net worth of 46.26 billion as of September 10, 2025. Its market cap has increased by 26.65% in one year.
Market Cap
46.26B
Enterprise Value
43.37B
Revenue
13.74B
Ranking
n/a
PE Ratio
27.59
Stock Price
507.50
Market Cap Chart
Since July 29, 1998, NSE:INDRAMEDCO's market cap has increased from 595.87M to 46.26B, an increase of 7,663.85%. That is a compound annual growth rate of 17.39%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Sep 10, 2025 | 46.26B | -3.49% |
| Dec 31, 2024 | 47.94B | 203.22% |
| Dec 29, 2023 | 15.81B | 107.52% |
| Dec 30, 2022 | 7.62B | 9.13% |
| Dec 31, 2021 | 6.98B | 33.25% |
| Dec 31, 2020 | 5.24B | 44.50% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Sun Pharmaceutical Industries | 3,819.02B |
| Divi's Laboratories | 1,593.48B |
| Cipla | 1,263.17B |
| Apollo Hospitals Enterprise | 1,140.07B |
| Mankind Pharma | 1,076.68B |
| Zydus Lifesciences | 1,042.06B |
| Fortis Healthcare | 730.16B |
| Alkem Laboratories | 638.00B |